Pragma Bio Strengthens Strategic Leadership with Addition of Esteemed Advisors and an Independent Board Member tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Deka Biosciences ("Deka") today announced the appointments of Stanley Frankel, M.D., FACP, as senior clinical advisor, interim chief medical.
Deka Biosciences Adds Industry Veterans to its Executive Leadership Team and Board of Directors tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Framingham, MA (PRWEB) September 26, 2022 Olaris, Inc., a precision medicine company leveraging metabolomics and machine learning for the discovery and
Press release content from Business Wire. The AP news staff was not involved in its creation.
Affinivax Appoints Stuart Chaffee, PhD, as Chief Business Officer
April 20, 2021 GMT
Affinivax Chief Business Officer Stuart Chaffee PhD (Photo: Business Wire)
CAMBRIDGE, Mass. (BUSINESS WIRE) Apr 20, 2021
Affinivax, Inc. (“Affinivax”), a clinical stage biopharmaceutical company pioneering the development of a novel class of vaccines with its MAPS™ (Multiple Antigen Presenting System) platform, today announced that Stuart Chaffee, PhD, has joined the company as Chief Business Officer. Dr. Chaffee brings to Affinivax extensive experience in business operations, finance and corporate development, including previous roles as Chief Business Officer and CFO at Praxis Precision Medicines and as Head of Business Operations and Co-founder of Kymera Therapeutics.